These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

464 related articles for article (PubMed ID: 23792936)

  • 41. Cross-sectional and longitudinal associations between insulin-like growth factor I and metabolic syndrome: a general population study in German adults.
    Friedrich N; Nauck M; Schipf S; Völzke H; Brabant G; Wallaschofski H
    Diabetes Metab Res Rev; 2013 Sep; 29(6):452-62. PubMed ID: 23576494
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Age-related reference intervals for bone turnover markers from an Australian reference population.
    Jenkins N; Black M; Paul E; Pasco JA; Kotowicz MA; Schneider HG
    Bone; 2013 Aug; 55(2):271-6. PubMed ID: 23603243
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cross-sectional evaluation of bone metabolism in men.
    Szulc P; Garnero P; Munoz F; Marchand F; Delmas PD
    J Bone Miner Res; 2001 Sep; 16(9):1642-50. PubMed ID: 11547833
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparison of two automated assays of BTM (CTX and P1NP) and reference intervals in a Danish population.
    Jørgensen NR; Møllehave LT; Hansen YBL; Quardon N; Lylloff L; Linneberg A
    Osteoporos Int; 2017 Jul; 28(7):2103-2113. PubMed ID: 28455749
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Bone turnover alterations across the menopausal transition in south-eastern Chinese women [corrected].
    Ma L; Song Y; Li C; Wang E; Zheng D; Qu F; Zhou J
    Climacteric; 2016 Aug; 19(4):400-5. PubMed ID: 27147201
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The relationship between the GH/IGF-I axis and serum markers of bone turnover metabolism in healthy children.
    Léger J; Mercat I; Alberti C; Chevenne D; Armoogum P; Tichet J; Czernichow P
    Eur J Endocrinol; 2007 Nov; 157(5):685-92. PubMed ID: 17984250
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Serum insulin-like growth factor I and its binding protein 3 in their relation to intima-media thickness: results of the study of health in Pomerania (SHIP).
    Spilcke-Liss E; Friedrich N; Dörr M; Schminke U; Völzke H; Brabant G; Nauck M; Wallaschofski H
    Clin Endocrinol (Oxf); 2011 Jul; 75(1):70-5. PubMed ID: 21521279
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pegvisomant-induced serum insulin-like growth factor-I normalization in patients with acromegaly returns elevated markers of bone turnover to normal.
    Parkinson C; Kassem M; Heickendorff L; Flyvbjerg A; Trainer PJ
    J Clin Endocrinol Metab; 2003 Dec; 88(12):5650-5. PubMed ID: 14671148
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Serum levels of type I procollagen C-terminal propeptide, insulin-like growth factor-I (IGF-I), and IGF binding protein-3 in obese children and adolescents: relationship to gender, pubertal development, growth, insulin, and nutritional status.
    Falorni A; Bini V; Cabiati G; Papi F; Arzano S; Celi F; Sanasi M
    Metabolism; 1997 Aug; 46(8):862-71. PubMed ID: 9258266
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Bone turnover markers and insulin-like growth factor components in metastatic breast cancer: results from a randomised trial of exemestane vs megestrol acetate.
    Martinetti A; Zilembo N; Ferrari L; Massimini G; Polli A; La Torre I; Giovanazzi R; Pozzi P; Bidoli P; De Candis D; Seregni E; Bombardieri E; Bajetta E
    Anticancer Res; 2003; 23(4):3485-91. PubMed ID: 12926095
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The relationship between bone turnover and body weight, serum insulin-like growth factor (IGF) I, and serum IGF-binding protein levels in patients with anorexia nervosa.
    Hotta M; Fukuda I; Sato K; Hizuka N; Shibasaki T; Takano K
    J Clin Endocrinol Metab; 2000 Jan; 85(1):200-6. PubMed ID: 10634387
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Traditional and novel bone remodeling markers in premenopausal and postmenopausal women.
    Botella S; Restituto P; Monreal I; Colina I; Calleja A; Varo N
    J Clin Endocrinol Metab; 2013 Nov; 98(11):E1740-8. PubMed ID: 24001743
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Association between serum insulin-like growth factor (IGF) I and IGF binding protein-3 and lung function.
    Gläser S; Friedrich N; Ewert R; Schäper C; Nauck M; Dörr M; Völzke H; Felix SB; Krebs A; Wallaschofski H; Koch B
    J Clin Endocrinol Metab; 2009 Jul; 94(7):2452-8. PubMed ID: 19401363
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Insulin-like growth factor-I and bone mineral density.
    Collins D; Woods A; Herd R; Blake G; Fogelman I; Wheeler M; Swaminathan R
    Bone; 1998 Jul; 23(1):13-6. PubMed ID: 9662125
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Down-regulation of the serum stimulatory components of the insulin-like growth factor (IGF) system (IGF-I, IGF-II, IGF binding protein [BP]-3, and IGFBP-5) in age-related (type II) femoral neck osteoporosis.
    Boonen S; Mohan S; Dequeker J; Aerssens J; Vanderschueren D; Verbeke G; Broos P; Bouillon R; Baylink DJ
    J Bone Miner Res; 1999 Dec; 14(12):2150-8. PubMed ID: 10620075
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Short-term changes in bone formation markers following growth hormone (GH) treatment in short prepubertal children with a broad range of GH secretion.
    Andersson B; Swolin-Eide D; Magnusson P; Albertsson-Wikland K
    Clin Endocrinol (Oxf); 2015 Jan; 82(1):91-9. PubMed ID: 24818653
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The association of testosterone, sex hormone-binding globulin, and insulin-like growth factor-1 with bone parameters in Korean men aged 50 years or older.
    Kim HJ; Koo HS; Kim YS; Kim MJ; Kim KM; Joo NS; Haam JH
    J Bone Miner Metab; 2017 Nov; 35(6):659-665. PubMed ID: 27873076
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of the treadmill walking exercise on the biochemical bone markers.
    Kitareewan W; Boonhong J; Janchai S; Aksaranugraha S
    J Med Assoc Thai; 2011 Oct; 94 Suppl 5():S10-6. PubMed ID: 22338920
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Biochemical markers of recombinant human insulin-like growth factor-I (rhIGF-I)/rhIGF binding protein-3 (rhIGFBP-3) misuse in athletes.
    Guha N; Erotokritou-Mulligan I; Nevitt SP; Francis M; Bartlett C; Cowan DA; Bassett EE; Sönksen PH; Holt RI
    Drug Test Anal; 2013; 5(11-12):843-9. PubMed ID: 24173773
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mortality and serum insulin-like growth factor (IGF)-I and IGF binding protein 3 concentrations.
    Friedrich N; Haring R; Nauck M; Lüdemann J; Rosskopf D; Spilcke-Liss E; Felix SB; Dörr M; Brabant G; Völzke H; Wallaschofski H
    J Clin Endocrinol Metab; 2009 May; 94(5):1732-9. PubMed ID: 19223521
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.